Drug therapy for threatened premature birth


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Premature birth (PB) is a complex sociomedical problem that is associated with the improved quality of further life in preterm babies and entails material and economic costs. The obstetricians’ task is to prepare the fetus for preterm birth, by using adequate and simultaneously safe medications. This literature review deals with the analysis of current methods for determination and therapy (secondary medical prevention) for threatened/active PB.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Z. Khodzhaeva

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation

Email: z_khodzhaeva@oparina4.ru
Moscow

O. Fedotovskaya

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation

Email: o_fedotovskaya@oparina4.ru
Moscow

A. Kholin

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation

Email: a_kholin@oparina4.ru
Moscow

Әдебиет тізімі

  1. Menon R. Preterm birth: a global burden on maternal and child health. Pathog. Glob. Health. 2012; 106(3): 139-40.
  2. Nour N.M. Premature delivery and the millennium development goal. Rev. Obstet. Gynecol. 2012; 5(2): 100-5.
  3. Gotsch F, Gotsch F, Romero R., Erez O., Vaisbuch E, Kusanovic J.P. et al. The preterm parturition syndrome and its implications for understanding the biology, risk assessment, diagnosis, treatment and prevention of preterm birth. J. Matern. Fetal Neonatal Med. 2009; 22(Suppl.2): 5-23. doi: 10.1080/14767050902860690.
  4. Menon R. Spontaneous preterm birth, a clinical dilemma: etiologic, pathophysiologic and genetic heterogeneities and racial disparity. Acta Obstet. Gynecol. Scand. 2008; 87(6): 590-600.
  5. Alfirevic Z., Allen-Coward F, Molina F, Vinuesa C.P., Nicolaides K. Targeted therapy for threatened preterm labor based on sonographic measurement of the cervical length: a randomized controlled trial. Ultrasound Obstet. Gynecol. 2007; 29(1): 47-50.
  6. Ходжаева З.С., Сидельникова В.М. Эффективность применения новых диагностических тестов для определения начала родовой деятельности и несвоевременного излития околоплодных вод. Вопросы гинекологии, акушерства и перинатологии. 2007; 6(1): 47-51.
  7. Di Renzo G.C., Cabero L.R., Facchinetti F., Antsaklis A., Breborowicz G, Gratacos E. et al. Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth. J. Matern. Fetal Neonatal Med. 2011; 24(5): 659-67.
  8. Lee H.C., Lyndon A., Blumenfeld Y.J., Dudley R.A., Gould J.B. Antenatal steroid administration for premature infants in California. Obstet. Gynecol. 2011; 117(3): 603-9.
  9. Surbek D., Drack G., Irion O., Nelle M., Huang D., Hoesli I. Antenatal corticosteroids for fetal lung maturation in threatened preterm delivery: indications and administration. Arch. Gynecol. Obstet. 2012; 286(2): 277-81.
  10. Bevilacqua E., Brunelli R., Anceschi M.M. Review and metaanalysis: benefits and risks of multiple courses of antenatal corticosteroids. J. Matern. Fetal Neonatal Med. 2010; 23: 244-60.
  11. McKinlay C.J., Crowther C.A., Middleton P., Harding J.E. Repeat antenatal glucocorticoids for women at risk of preterm birth: a Cochrane Systematic Review. Am. J. Obstet. Gynecol. 2012; 206(3): 187-94.
  12. Peltoniemi O.M., Kari M.A., Hallman M. Repeated antenatal corticosteroid treatment: a systematic review and meta-analysis. Acta Obstet. Gynecol. Scand. 2011; 90: 719-27.
  13. Newnham J.P., Jobe A.H. Should we be prescribing repeated courses of antenatal corticosteroids? Semin. Fetal Neonatal Med. 2009; 14(3): 157-63.
  14. Gyamfi-Bannerman C., Gilbert S., Landon M.B., Spong C.Y., Rouse D.J., Varner M.W. et al. Effect of antenatal corticosteroids on respiratory morbidity in singletons after late-preterm birth. Obstet. Gynecol. 2012; 119: 555-9.
  15. Kamath-Rayne B.D., DeFranco E.A., Marcotte M.P. Antenatal steroids for treatment of fetal lung immaturity after 34 weeks of gestation: an evaluation of neonatal outcomes. Obstet. Gynecol. 2012; 119(5): 909-16.
  16. Royal College of Obstetricians and Gynaecologists (RCOG). Tocolysis for women in preterm labour. London: Royal College of Obstetricians and Gynaecologists; 2011: Feb. 13p. (Green-top guideline; no. 1b).
  17. Mercer B.M., Merlino A.A.; Society for Maternal-Fetal Medicine. Magnesium sulfate for preterm labor and preterm birth. Obstet. Gynecol. 2009; 114(3): 650-68.
  18. Dodd J.M., Crowther C.A., Middleton P. Oral betamimetics for maintenance therapy after threatened preterm labour. Cochrane Database Syst. Rev. 2012; (12): CD003927. doi: 10.1002/14651858.CD003927.pub3.
  19. Yamasmit W., Chaithongwongwatthana S., Tolosa J.E., Limpongsanurak S., Pereira L., Lumbiganon P. Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy. Cochrane Database Syst. Rev. 2012; (9): CD004733. doi: 10.1002/14651858.CD004733.pub3
  20. Landau R., Morales M.A., Antonarakis S.E., Blouin J.L., Smiley R.M. Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor. Clin. Pharmacol. Ther. 2005; 78(6): 656-63.
  21. Fonseca E.B., Bittar R.E., Carvalho M.H., Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am. J. Obstet. Gynecol. 2003; 188: 419-24.
  22. Lyell D.J., Pullen K.M., Mannan J., Chitkara U., Druzin M.L., Caughey A.B. et al. Maintenance nifedipine tocolysis compared with placebo: a randomized controlled trial. Obstet. Gynecol. 2008; 112: 1221-6.
  23. King J.F., Flenady V.J., Papatsonis D.N., Dekker G.A., Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst. Rev. 2003; (1): CD002255.
  24. Conde-Agudelo А., Romero R., Kusanovic P.J. Nifedipine for the management of preterm labor: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2011; 204(2): 134; e1-20.
  25. Thornton J.G., Deshpande R. Atosiban clinical experience -efficacy and safety. Eur. Obstet. Gynecol. 2009; 4(1): 46-9.
  26. Husslein P., Roura L.C., Dudenhausen J.W., Helmer H. Atosiban versus usual care for the management of preterm labor. J. Perinat. Med. 2007; 35: 305-13.
  27. Salim R., Garmi G., Nachum Z., Zafran N., Baram S., Shalev Е. Nifedipine compared with atosiban for treating preterm labor: a randomized controlled trial. Obstet. Gynecol. 2012; 120(6): 1323-31.
  28. Wolf H.T., Hegaard H.K., Greisen G., Huusom L., Hedegaard M. Treatment with magnesium sulphate in preterm birth: a systematic review and meta-analysis of observational studies. J. Obstet. Gynaecol. 2012; 32(2): 135 -40.
  29. Doyle L.W., Crowther C.A., Middleton P., Marret S., Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst. Rev. 2009; (1): CD004661. doi: 10.1002/14651858.CD004661.pub3.
  30. Bain E., Middleton P., Crowther C.A. Different magnesium sulphate regimens for neuroprotection of the fetus for women at risk of preterm birth. Cochrane Database Syst. Rev. 2012; (2): CD009302. doi: 10.1002/14651858.CD009302.pub2.
  31. American College of Obstetricians and Gynecologists Committee on Obstetric Practice; Society for Maternal-Fetal Medicine. Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection. Obstet. Gynecol. 2010; 115(3): 669-71.
  32. Dowling O., Chatterjee P., Gupta M., Tam Tam H.B., Xue X., Lewis D. et al. Magnesium sulfate reduces bacterial LPS-induced inflammation at the maternal-fetal interface. Placenta. 2012; 33(5): 392-8.
  33. Loe S.M., Sanchez-Ramos L., Kaunitz A.M. Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet. Gynecol. 2005; 106(1): 173-9.
  34. Hassan S.S., Romero R., Vidyadhari D., Fusey S., Baxter J.K., Khandelwal M. et al. Vaginal progesterone for the prevention of preterm birth in women with a sonographic short cervix; a multicentre, randomised, double-blind, placebo-controlled trial. Ultrasound Obstet. Gynecol. 2011; 38: 18-31.
  35. Romero R., Nicolaides K., Conde-Agudelo A., Tabor A., O’Brien J.M., Cetingoz E. et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and meta-analysis of individual patient data. Am. J. Obstet. Gynecol. 2012; 206(2): 124; e1-19.
  36. Romero R., Yeo L., Miranda J., Hassan S.S., Conde-Agudelo A., Chaiworapongsa T. A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix. J. Perinat. Med. 2013; 41(1): 27-44.
  37. Bioavailabillity of progesterone -intravaginal administration. Dr Kade Pharmazeutische Fabrik GmbH., July 19, 1999. MKL2790. 58 p.
  38. Meis P.J., Klebanoff M., Thom E., Dombrowski M.P., Sibai B., Moawad A.H. et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N. Engl. J. Med. 2003; 348(24): 2379-85.
  39. Calda P. Safety signals of 17-OHP-C use in pregnancy and efficacy in the prevention of preterm birth. J. Matern. Fetal Neonatal Med. 2009; 22: 540-2.
  40. Cahill A.G., Odibo A.O., Caughey A.B., Stamilio D.M., Hassan S.S., Macones G.A., Romero R. Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis. Am. J. Obstet. Gynecol. 2010; 202(6): 548; e1-8.
  41. Werner E.F., Han C.S., Pettker C.M., Buhimschi C.S., Copel J.A., Funai E.F., Thung S.F. Universal cervical-length screening to prevent preterm birth: a cost-effectiveness analysis. Ultrasound Obstet. Gynecol. 2011; 38(1): 32-7.
  42. Crowley P. Antibiotics for preterm prelabour rupture of membranes. In: Enkin M.W., Keirse M.J., Renfrew M.J., Neilson J.P., Crowther C., eds. Pregnancy and childbirth module of the the cochrane pregnancy and childbirth database. Issue 2. Oxford: Update Software; 1995.
  43. Kenyon S., Taylor D., Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet. 2001; 357: 979-88.
  44. Andrews W.W., Sibai B.M., Thom E.A., Dudley D., Ernest J.M., McNellis D. et al. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet. Gynecol. 2003; 101(5,Pt1): 847-55.
  45. Kenyon S., Pike K., Jones D.R., Brocklehurst P., Marlow N., Salt A., Taylor D.J. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet. 2008; 372(9646): 1319-27.
  46. Kenyon S., Pike K., Jones D.R., Brocklehurst P., Marlow N., Salt A., Taylor D.J. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet. 2008; 372 (9646): 1319-27.
  47. King J., Flenady V. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst. Rev. 2002; (4): CD000246.
  48. Verani J.R., McGee L., Schrag S.J. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm. Rep. 2010; 59: 1-36.
  49. Winer N. Management of threatening preterm labor with intact membranes: indications for antibiotics. J. Gynecol. Obstet. Biol. Reprod. 2002; 31(Suppl.7): 574-83.
  50. Thorp J. Antibiotic therapy for the treatment of preterm labor: a review of the evidence. Am. J. Obstet. Gynecol. 2002; 186(3): 587-92.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2013

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>